The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Open accessAbstract
Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has illuminated the extensive intertumoral heterogeneity of medulloblastoma, identifying four distinct molecular subgroups. Group 3 and group 4 subgroup medulloblastomas account for most paediatric cases; yet, oncogenic drivers for these subtypes remain largely unidentified. Here we describe a series of prevalent, highly disparate genomic structural variants, restricted to groups 3 and 4, resulting in specific and mutually exclusive activation of the growth factor independent 1 family proto-oncogenes, GFI1 and GFI1B. Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity. Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have shown that the ‘hijacking’ of enhancers can lead to overexpression of oncogenes (for example, growth factor independent 1 family oncogenes (GFI1 and GFI1B)) in medulloblastoma13”
From Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (2020) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Krueger, F., & Andrews, S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,324
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Mapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Cited by
Sorted by citations
Items 201–300 of 649
Copy number alterations unmasked as enhancer hijackers
Beroukhim, R., Zhang, X., & Meyerson, M. (2017) · Nature Genetics · doi:10.1038/ng.3754 · Cited by 46
Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis
Wang, W., Li, L., & Cui, J. (2020) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00371-7 · Cited by 45
Self-citationLiu, B., Conroy, J. M., Morrison, C. D., Odunsi, A., Qin, M., Wei, L., Trump, D. L., Johnson, C. S., Liu, S., & Wang, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3491 · Cited by 45
Transcription Factor GFI1B in Health and Disease
Anguita, E., Candel, F. J., Chaparro, A., & Roldán‐Etcheverry, J. J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00054 · Cited by 45
Ray, S., Chaturvedi, N. K., Bhakat, K. K., Rizzino, A., & Mahapatra, S. (2021) · Diagnostics · doi:10.3390/diagnostics12010061 · Cited by 49
Beyes, S., Bediaga, N. G., & Zippo, A. (2021) · Cancers · doi:10.3390/cancers13194969 · Cited by 44
Global impact of somatic structural variation on the cancer proteome
Chen, F., Zhang, Y., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2023) · Nature Communications · doi:10.1038/s41467-023-41374-8 · Cited by 46
Genetic and molecular alterations across medulloblastoma subgroups
Skowron, P., Ramaswamy, V., & Taylor, M. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1333-8 · Cited by 42
Self-citationCytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options
Söderberg‐Nauclér, C. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i1.1 · Cited by 42
RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
Garancher, A., Suzuki, H., Haricharan, S., Chau, L. Q., Masihi, M. B., Rusert, J. M., Norris, P. S., Carrette, F., Romero, M. M., Morrissy, A. S., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0628-4 · Cited by 42
Self-citationRetractedCui, S., Wu, Q., Liu, M., Su, M., Liu, S., Shao, L., Han, X., & He, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03538-6 · Cited by 42
Functional analysis of structural variants in single cells using Strand-seq
Jeong, H., Grimes, K., Rauwolf, K. K., Bruch, P., Rausch, T., Hasenfeld, P., Benito, E., Roider, T., Sabarinathan, R., Porubskỳ, D., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01551-4 · Cited by 45
Self-citationThe Stochastic Genome and Its Role in Gene ExpressionPreprint
Bohrer, C. H., & Larson, D. R. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040386 · Cited by 43
Chen, Z., Ioris, R. M., Richardson, S., Van Ess, A. N., Vendrell, I., Kessler, B. M., Buffa, F. M., Busino, L., Clifford, S. C., Bullock, A. N., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00983-4 · Cited by 41
Risk variants disrupting enhancers of T H 1 and T REG cells in type 1 diabetes
Gao, P., Uzun, Y., He, B., Salamati, S., Coffey, J., Tsalikian, E., & Tan, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815336116 · Cited by 41
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia
Smeenk, L., Ottema, S., Mulet‐Lazaro, R., Ebert, A., Havermans, M., Varea, A. A., Fellner, M., Pastoors, D., van Herk, S., Erpelinck-Verschueren, C. A. J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1793 · Cited by 41
An oncogenic enhancer encodes selective selenium dependency in AML
Eagle, K., Jiang, Y., Shi, X. E., Li, M., Obholzer, N. D., Hu, T., Perez, M. W., Koren, J. V., Kitano, A., Yi, J. S., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.01.003 · Cited by 40
Structural variants in the 3D genome as drivers of disease
Sreenivasan, V. K. A., Yumiceba, V., & Spielmann, M. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00862-x · Cited by 45
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer
Okabe, A., & Kaneda, A. (2021) · Cancer Science · doi:10.1111/cas.14884 · Cited by 41
Kelly, M. R., Wiśniewska, K., Regner, M. J., Lewis, M. W., Perreault, A. A., Davis, E. S., Phanstiel, D. H., Parker, J. S., & Franco, H. L. (2022) · Nature Communications · doi:10.1038/s41467-022-31919-8 · Cited by 42
Rheinbay, E., Nielsen, M. M., Abascal, F., Tiao, G., Hornshøj, H., Hess, J. M., Pedersen, R. I., Feuerbach, L., Sabarinathan, R., Madsen, T. L., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/237313 · Cited by 40
Hemming, M. L., Lawlor, M. A., Zeid, R., Lesluyes, T., Fletcher, J. A., Raut, C. P., Sicińska, E., Chibon, F., Armstrong, S. A., Demetri, G. D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802079115 · Cited by 39
3DIV update for 2021: a comprehensive resource of 3D genome and 3D cancer genome
Kim, K., Jang, I., Kim, M., Choi, J., Kim, M.-S., Lee, B.-W., & Jung, I. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1078 · Cited by 39
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Dubois, F. P. B., Shapira, O., Greenwald, N. F., Zack, T. I., Wala, J. A., Tsai, J. W., Crane, A., Baguette, A., Hadjadj, D., Harutyunyan, A. S., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00403-z · Cited by 42
Self-citationDevelopmental origins shape the paediatric cancer genome
Chen, X., Yang, W., Roberts, C. W. M., & Zhang, J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00684-9 · Cited by 49
In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview
Li, Z., & Langhans, S. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.620831 · Cited by 39
Range extender mediates long-distance enhancer activity
Bower, G., Hollingsworth, E. W., Jacinto, S. H., Alcantara, J. A., Clock, B., Cao, K., Liu, M., Dziulko, A., Alcaina-Caro, A., Xu, Q., et al. (2025) · Nature · doi:10.1038/s41586-025-09221-6 · Cited by 49
Medulloblastoma in the Molecular Era
Kuzan-Fischer, C. M., Juraschka, K., & Taylor, M. D. (2018) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2018.0028 · Cited by 37
Self-citationVisvanathan, A., Saulnier, O., Chen, C., Haldipur, P., Orisme, W., Delaidelli, A., Shin, S., Millman, J., Bryant, A., Abeysundara, N., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.011 · Cited by 37
Self-citationRevisiting 3D chromatin architecture in cancer development and progression
Feng, Y., & Pauklin, S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa747 · Cited by 36
Genome-guided discovery of cancer therapeutic targets
Konda, P., Garinet, S., Allen, E. M. V., & Viswanathan, S. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112978 · Cited by 36
Mortenson, K. L., Dawes, C., Wilson, E. R., Patchen, N. E., Johnson, H. E., Gertz, J., Bailey, S. D., Yang, J., Varley, K. E., & Zhang, X. (2024) · Nature Communications · doi:10.1038/s41467-024-50387-w · Cited by 35
Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity
Fagnocchi, L., Poli, V., & Zippo, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2820-1 · Cited by 38
Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling
Lee, D., Gimple, R. C., Wu, X., Prager, B. C., Qiu, Z., Wu, Q., Daggubati, V., Mariappan, A., Gopalakrishnan, J., Sarkisian, M. R., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci163592 · Cited by 36
SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells
Kuai, X., Li, L., Chen, R., Wang, K., Chen, M., Cui, B., Zhang, Y., Li, J., Zhu, H., Zhou, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4032 · Cited by 34
Kiehlmeier, S., Rafiee, M., Bakr, A., Mika, J., Kruse, S., Müller, J., Schweiggert, S., Herrmann, C., Sigismondo, G., Schmezer, P., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01235-z · Cited by 34
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
Voskamp, M. J., Li, S., van Daalen, K. R., Crnko, S., ten Broeke, T., & Bovenschen, N. (2021) · Cancers · doi:10.3390/cancers13215387 · Cited by 37
Modeling and Targeting MYC Genes in Childhood Brain Tumors
Hutter, S., Bolin, S., Weishaupt, H., & Swartling, F. J. (2017) · Genes · doi:10.3390/genes8040107 · Cited by 38
Mouse medulloblastoma driven by CRISPR activation of cellular Myc
Vo, B. T., Kwon, J. A., Li, C., Finkelstein, D., Xu, B., Orr, B. A., Sherr, C. J., & Roussel, M. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-24956-1 · Cited by 36
Zou, H., Poore, B., Broniscer, A., Pollack, I. F., & Hu, B. (2020) · Cancers · doi:10.3390/cancers12030643 · Cited by 33
A unifying model for extrachromosomal circular DNA load in eukaryotic cells
Arrey, G., Keating, S. T., & Regenberg, B. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.002 · Cited by 37
Mack, S. C., & Northcott, P. A. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.9921 · Cited by 32
Self-citationInsights about genome function from spatial organization of the genome
Roy, S. S., Mukherjee, A. K., & Chowdhury, S. (2018) · Human Genomics · doi:10.1186/s40246-018-0140-z · Cited by 32
Deregulated proliferation and differentiation in brain tumors
Swartling, F. J., Čančer, M., Frantz, A., Weishaupt, H., & Persson, A. I. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-2046-y · Cited by 32
Tonekaboni, S. A. M., Mazrooei, P., Kofia, V., Haibe‐Kains, B., & Lupien, M. (2019) · Genome Research · doi:10.1101/gr.248658.119 · Cited by 32
Medulloblastoma: experimental models and reality
Neumann, J. E., Swartling, F. J., & Schüller, U. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1753-3 · Cited by 31
Yang, Y., Cui, H., & Wang, X. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1553604 · Cited by 31
Yuan, C., Chen, H., Tu, S., Huang, H.-Y., Pan, Y., Gui, X., Kuang, M., Shen, X., Zheng, Q., Zhang, Y., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02376-1 · Cited by 31
Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer
DeVaux, R. S., & Herschkowitz, J. I. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9414-2 · Cited by 32
Perturbing Enhancer Activity in Cancer Therapy
Hamdan, F. H., & Johnsen, S. A. (2019) · Cancers · doi:10.3390/cancers11050634 · Cited by 31
Somatic structural variant formation is guided by and influences genome architecturePreprint
Sidiropoulos, N., Mardin, B. R., Rodríguez-González, F. G., Bochkov, I. D., Garg, S., Stütz, A. M., Korbel, J. O., Aiden, E. L., & Weischenfeldt, J. (2022) · Genome Research · doi:10.1101/gr.275790.121 · Cited by 32
Self-citationHijacked enhancer–promoter and silencer–promoter loops in cancer
Wang, X., & Yue, F. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102199 · Cited by 32
Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Liu, T., Wang, J., Yang, H., Jin, Q., Wang, X., Fu, Y., Luan, Y., Wang, Q., Youngblood, M. W., Lu, X., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1858 · Cited by 30
Etiology of super-enhancer reprogramming and activation in cancer
Zhou, R. W., & Parsons, R. E. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00502-w · Cited by 31
Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time
Holgado, B., Stücklin, A. G., Garzia, L., Daniels, C., & Taylor, M. D. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035434 · Cited by 30
Self-citationEpigenetic regulation in medulloblastoma
Yi, J., & Wu, J. I. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.09.003 · Cited by 32
Heterogeneity and tumoral origin of medulloblastoma in the single-cell era
Sheng, H., Li, H., Zeng, H., Zhang, B., Yu, L., Liu, X., Xu, Z., Zhang, J., & Zhang, L. (2024) · Oncogene · doi:10.1038/s41388-024-02967-9 · Cited by 30
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
Chen, Y., Li, X., Li, G. L., Tao, Y., Zhuo, R., Cao, H., Jiao, W., Li, Z., Zhu, Z., Fang, F., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00769-8 · Cited by 29
Ling, X., Liu, X., Jiang, S., Fan, L., & Ding, J. (2022) · Cell Regeneration · doi:10.1186/s13619-022-00145-4 · Cited by 29
Selective and mechanistic sources of recurrent rearrangements across the cancer genomePreprint
Wala, J. A., Shapira, O., Li, Y., Craft, D., Schumacher, S. E., Imielinski, M. B., Haber, J. E., Roberts, N. D., Yao, X., Stewart, C., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/187609 · Cited by 30
Galupa, R., & Heard, É. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.035030 · Cited by 30
Determinants and role of chromatin organization in acute leukemia
Fang, C., Rao, S., Crispino, J. D., & Ntziachristos, P. (2020) · Leukemia · doi:10.1038/s41375-020-0981-z · Cited by 30
Epigenetic pathways and plasticity in brain tumors
Suter, R. K., Rodríguez‐Blanco, J., & Ayad, N. G. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105060 · Cited by 28
G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
Zhang, R., Shu, H., Wang, Y., Tao, T., Tu, J., Wang, C., Mergny, J., & Sun, X. S. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3089 · Cited by 31
Nuclear genome organization in fungi: from gene folding to Rabl chromosomes
Torres, D. E., Reckard, A. T., Klocko, A. D., & Seidl, M. F. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad021 · Cited by 29
Put away your microscopes: the ependymoma molecular era has begun
Mack, S. C., & Taylor, M. D. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000411 · Cited by 27
Self-citationDynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer
Du, Y., Gu, Z., Li, Z., Yuan, Z., Zhao, Y., Zheng, X., Bo, X., Chen, H., & Wang, C. (2022) · Advanced Science · doi:10.1002/advs.202200818 · Cited by 28
Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models
Antonica, F., Aiello, G., Soldano, A., Abballe, L., Miele, E., & Tiberi, L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.818696 · Cited by 28
Botten, G., Zhang, Y., Dudnyk, K., Kim, Y., Liu, X., Sanders, J. T., Imanci, A., Droin, N., Cao, H., Kaphle, P., et al. (2022) · Blood · doi:10.1182/blood.2022017555 · Cited by 29
Kent, D., Marchetti, L., Mikulášová, A., Russell, L. J., & Rico, D. (2023) · BioEssays · doi:10.1002/bies.202200239 · Cited by 31
Luo, Z., Liao, Y., Xin, D., Berry, K., Ogurek, S., Dong, X., Li, H., Yu, J., Zhang, F., Han, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36400-8 · Cited by 26
Self-citationXu, J., Margol, A., Shukla, A., Ren, X., Finlay, J. L., Krieger, M. D., Gilles, F. H., Couch, F. J., Aziz, M., Fung, E. T., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00191 · Cited by 27
Somatic structural variation and cancer
Tubío, J. M. C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv016 · Cited by 27
Enhancer Dysfunction in 3D Genome and Disease
Xia, J., & Wei, G. (2019) · Cells · doi:10.3390/cells8101281 · Cited by 26
Rusert, J. M., Wu, X., Eberhart, C. G., Taylor, M. D., & Wechsler‐Reya, R. J. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.11.015 · Cited by 26
Self-citationGoddard, J., Castle, J., Southworth, E., Fletcher, A., Crosier, S., Martín‐Guerrero, I., García-Ariza, M., Navajas, A., Masliah‐Planchon, J., Bourdeaut, F., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02566-0 · Cited by 25
Self-citationLong, Y., Wendel, J. F., Zhang, X., & Wang, M. (2023) · Trends in Plant Science · doi:10.1016/j.tplants.2023.11.009 · Cited by 26
Next-generation sequencing and empowering personalised cancer medicine
McDermott, U. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.10.008 · Cited by 25
DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?
Ordóñez, R., Martínez‐Calle, N., Agirre, X., & Prósper, F. (2019) · Cancers · doi:10.3390/cancers11101424 · Cited by 26
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival
Gillani, R., Seong, B. K. A., Crowdis, J. P., Conway, J. R., Dharia, N. V., Alimohamed, S. I., Haas, B. J., Han, K., Park, J., Dietlein, F., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0791 · Cited by 28
Extrachromosomal Circular DNA: A New Target in Cancer
Wu, P., Liu, Y., Zhou, R., Liu, L., Zeng, H., Xiong, F., Zhang, S., Gong, Z., Zhang, W., Guo, C. J., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.814504 · Cited by 25
Genomic structural variation: A complex but important driver of human evolution
Soto, D. C., Uribe‐Salazar, J. M., Shew, C. J., Sekar, A., McGinty, S. P., & Dennis, M. Y. (2023) · American Journal of Biological Anthropology · doi:10.1002/ajpa.24713 · Cited by 25
Yan, H., Tian, S., Slager, S. L., & Sun, Z. (2016) · Epigenomics · doi:10.2217/epi-2016-0053 · Cited by 25
Sandén, E., Dyberg, C. H., Krona, C. C., Gallo-Oller, G., Olsen, T. K., Pérez, J. E., Wickström, M., Estekizadeh, A., Kool, M., Visse, E., et al. (2017) · Scientific Reports · doi:10.1038/srep46366 · Cited by 25
Self-citationAn oncolytic measles virus–sensitive Group 3 medulloblastoma model in immune-competent mice
Lal, S., Carrera, D. A., Phillips, J. J., Weiss, W. A., & Raffel, C. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy089 · Cited by 25
In silico analysis of long non-coding RNAs in medulloblastoma and its subgroups
Joshi, P. K., Jallo, G. I., & Perera, R. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104873 · Cited by 25
Three-dimensional genome: developmental technologies and applications in precision medicine
Li, Y., Tao, T., Du, L., & Zhu, X. M. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0737-7 · Cited by 24
Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis
Chai, P., Yu, J., Jia, R., Wen, X., Ding, T., Zhang, X., Ni, H., Jia, R., Ge, S., Zhang, H., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1051 · Cited by 24
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
Shrestha, S., Morcavallo, A., Gorrini, C., & Chesler, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.694320 · Cited by 24
Pioneering models of pediatric brain tumors
Grigore, F., Yang, S. J., Chen, C. C., & Koga, T. (2023) · Neoplasia · doi:10.1016/j.neo.2022.100859 · Cited by 24
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Zhuang, H.-H., Qu, Q., Teng, X.-Q., Dai, Y.-H., & Qu, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00934-0 · Cited by 24
MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma
Wang, C., Yun, Z., Zhao, T., Liu, X., & Ma, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430308 · Cited by 24
Altered TERT promoter and other genomic regulatory elements: occurrence and impact
Heidenreich, B., & Kumar, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30735 · Cited by 26
Medulloblastoma: an Old Diagnosis with New Promises
Szalontay, L., & Khakoo, Y. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00953-4 · Cited by 24
He, B., Gao, P., Ding, Y., Chen, C.-H., Chen, G., Chen, C., Kim, H., Tasian, S. K., Hunger, S. P., & Tan, K. (2020) · Science Advances · doi:10.1126/sciadv.aba3064 · Cited by 25
Pediatric embryonal brain tumors in the molecular era
Li, B. K., Al-Karmi, S. A., Huang, A., & Bouffet, É. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1714439 · Cited by 23
Chiliński, M., Sengupta, K., & Plewczyński, D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.08.007 · Cited by 23
Role of Enhancers in Development and Diseases
Maurya, S. S. (2021) · Epigenomes · doi:10.3390/epigenomes5040021 · Cited by 26
PPM1D Is a Therapeutic Target in Childhood Neural Tumors
Milosevic, J., Treis, D., Fransson, S. M., Gallo-Oller, G., Sveinbjørnsson, B., Eißler, N., Tanino, K., Sakaguchi, K., Martinsson, T., Wickström, M., et al. (2021) · Cancers · doi:10.3390/cancers13236042 · Cited by 23
Slika, H., Alimonti, P., Raj, D., Caraway, C. A., Alomari, S., Jackson, E. M., & Tyler, B. (2023) · Cancers · doi:10.3390/cancers15153889 · Cited by 24
Metadata
- Authors
- Northcott, P. A., Lee, C., Zichner, T., Stütz, A. M., Erkek, S., Kawauchi, D., Shih, D. J. H., Hovestadt, V., Zapatka, M., Sturm, D., Jones, D. T. W., Kool, M., Remke, M., Cavalli, F. M. G., Zuyderduyn, S., Bader, G. D., VandenBerg, S., Esparza, L. A., Ryzhova, M., Wang, W., Wittmann, A., Stark, S., Sieber, L., Seker-Cin, H., Linke, L., Kratochwil, F., Jäger, N., Buchhalter, I., Imbusch, C. D., Zipprich, G., Raeder, B., Schmidt, S., Diessl, N., Wolf, S., Wiemann, S., Brors, B., Lawerenz, C., Eils, J., Warnatz, H.-J., Risch, T., Yaspo, M.-L., Weber, U. D., Bartholomae, C. C., von Kalle, C., Turányi, E., Hauser, P., Sanden, E., Darabi, A., Siesjö, P., Sterba, J., Zitterbart, K., Sumerauer, D., van Sluis, P., Versteeg, R., Volckmann, R., Koster, J., Schuhmann, M. U., Ebinger, M., Grimes, H. L., Robinson, G. W., Gajjar, A., Mynarek, M., von Hoff, K., Rutkowski, S., Pietsch, T., Scheurlen, W., Felsberg, J., Reifenberger, G., Kulozik, A. E., von Deimling, A., Witt, O., Eils, R., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Korbel, J. O., Wechsler-Reya, R. J., & Pfister, S. M.
- Affiliations
- German Cancer Research Center (DE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- European Molecular Biology Laboratory (DE)
- Hospital for Sick Children (CA)
- University of Toronto (CA)
- University of California San Diego (US)
- Burdenko Neurosurgery Institute (RU)
- Max Planck Institute for Molecular Genetics (DE)
- Semmelweis University (HU)
- Lund University (SE)
- Masaryk University (CZ)
- Charles University (CZ)
- Amsterdam UMC Location University of Amsterdam (NL)
- Universitätsklinikum Tübingen (DE)
- Cincinnati Children's Hospital Medical Center (US)
- St. Jude Children's Research Hospital (US)
- University Medical Center Hamburg-Eppendorf (DE)
- University of Bonn (DE)
- Cnopf´sche Kinderklinik (DE)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Heidelberg (DE)
- Heidelberg University (DE)
- European Bioinformatics Institute (GB)
- Corresponding author
- Lichter, Peter
- Korbel, Jan O.
- Pfister, Stefan M.
- ORCID
- Northcott, Paul A.
- Lee, Catherine
- Zichner, Thomas
- Stütz, Adrian M.
- Erkek, Serap
- Kawauchi, Daisuke
- Shih, David J. H.
- Hovestadt, Volker
- Zapatka, Marc
- Sturm, Dominik
- Jones, David T. W.
- Kool, Marcel
- Remke, Marc
- Cavalli, Florence M. G.
- Bader, Gary D.
- VandenBerg, Scott
- Esparza, Lourdes Adriana
- Ryzhova, Marina
- Wang, Wei
- Linke, Linda
- Jäger, Natalie
- Buchhalter, Ivo
- Imbusch, Charles D.
- Raeder, Benjamin
- Schmidt, Sabine
- Wiemann, Stefan
- Brors, Benedikt
- Warnatz, Hans-Jörg
- Yaspo, Marie-Laure
- Darabi, Anna
- Siesjö, Peter
- Sumerauer, David
- Versteeg, Rogier
- Volckmann, Richard
- Schuhmann, Martin U.
- Ebinger, Martin
- Grimes, H. Leighton
- Robinson, Giles W.
- Gajjar, Amar
- Mynarek, Martin
- Rutkowski, Stefan
- Pietsch, Torsten
- Felsberg, Jörg
- Reifenberger, Guido
- Kulozik, Andreas E.
- Witt, Olaf
- Eils, Roland
- Gilbertson, Richard J.
- Korshunov, Andrey
- Taylor, Michael D.
- Lichter, Peter
- Korbel, Jan O.
- Pfister, Stefan M.
- Venue
- Nature
- Published
- 2014-06-22
- Volume
- 511
- Issue
- 7510
- Pages
- 428-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4201514
- OpenAlex
- W2161535481
- Cited by
- 642
- References
- 47
- Citations by year
- 2026: 26 · 2025: 47 · 2024: 51 · 2023: 59 · 2022: 66 · 2021: 75 · 2020: 62 · 2019: 64 · 2018: 51 · 2017: 49 · 2016: 47 · 2015: 36 · 2014: 6
- FWCI
- 23.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Semmelweis University Repository (Semmelweis University) (submittedVersion)
- Funders
- California Institute for Regenerative Medicine (LA1-01747)
- CureSearch for Children's Cancer
- Deutsches Krebsforschungszentrum
- European Commission (260791)
- Bundesministerium für Bildung und Forschung (01KU1201A, 01GS0883)
- Deutsche Krebshilfe (109252)
- Hospital for Sick Children
- Stichting Kinderen Kankervrij
- Nationales Centrum für Tumorerkrankungen Heidelberg
- Partenariat Canadien Contre Le Cancer
- National Institutes of Health (UL1TR001425, GM 103504)
- University of California, San Diego
- Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft
- National Cancer Institute (R01CA129541, CA159859, P30CA030199, R01CA159859, P01CA096832)
- National Institute of General Medical Sciences (P41GM103504)
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- medulloblastoma, enhancer hijacking, GFI1, GFI1B, oncogene activation, super-enhancers, structural variants, Group 3 medulloblastoma, Group 4 medulloblastoma, pediatric brain tumors, oncogenic drivers
- MeSH terms
- Animals, Child, Chromosomes, Human, Pair 9, DNA-Binding Proteins, Enhancer Elements, Genetic, Humans, Medulloblastoma, Oncogenes, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Mice, Genomic Structural Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
